Searched for
DONANEMAB COST AND ACCESS
Eli Lilly's Alzheimer's drug donanemab approved in India, but neurologists flag cost, access barriersA new drug for Alzheimer's, donanemab, has arrived in India. It aims to slow the disease's progression by clearing brain plaques. While off...
Eli Lilly sticks to premium pricing for its innovator drug ahead of generics waveEli Lilly remains optimistic about strong demand for its weight-loss and anti-diabetes injectable, tirzepatide (sold as Mounjaro), despite ...
New cancer-like rating system introduced for Alzheimer's diagnosisExperts have developed a new seven-point rating scale for diagnosing Alzheimer's disease based on cognitive and biological changes in patie...